[Federal Register Volume 79, Number 157 (Thursday, August 14, 2014)]
[Notices]
[Pages 47640-47641]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2014-19245]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[60Day-14-14ARR]


Proposed Data Collections Submitted for Public Comment and 
Recommendations

    The Centers for Disease Control and Prevention (CDC), as part of 
its continuing effort to reduce public burden, invites the general 
public and other Federal agencies to take this opportunity to comment 
on proposed and/or continuing information collections, as required by 
the Paperwork Reduction Act of 1995. To request more information on the 
below proposed project or to obtain a copy of the information 
collection plan and instruments, call 404-639-7570 or send comments to 
Leroy Richardson, 1600 Clifton Road, MS-D74, Atlanta, GA 30333 or send 
an email to [email protected].
    Comments submitted in response to this notice will be summarized 
and/or included in the request for Office of Management and Budget 
(OMB) approval. Comments are invited on: (a) Whether the proposed 
collection of information is necessary for the proper performance of 
the functions of the agency, including whether the information shall 
have practical utility; (b) the accuracy of the agency's estimate of 
the burden of the proposed collection of information; (c) ways to 
enhance the quality, utility, and clarity of the information to be 
collected; (d) ways to minimize the burden of the collection of 
information on respondents, including through the use of automated 
collection techniques or other forms of information technology; and (e) 
estimates of capital or start-up costs and costs of operation, 
maintenance, and purchase of services to provide information. Burden 
means the total time, effort, or financial resources expended by 
persons to generate, maintain, retain, disclose or provide information 
to or for a Federal agency. This includes the time needed to review 
instructions; to develop, acquire, install and utilize technology and 
systems for the purpose of collecting, validating and verifying 
information, processing and maintaining information, and disclosing and 
providing information; to train personnel and to be able to respond to 
a collection of information, to search data sources, to complete and 
review the collection of information; and to transmit or otherwise 
disclose the information. Written comments should be received within 60 
days of this notice.

Proposed Project

    Drug Overdose Response Investigation (DORI) Data Collections--New--
National Center for Injury Prevention and Control (NCIPC), Centers for 
Disease Control and Prevention (CDC).

Background and Brief Description

    State and local health authorities frequently call upon CDC's 
National Center for Injury Prevention and Control (NCIPC) to assist in 
their response to urgent public health problems resulting from drug 
use, misuse, abuse, and overdose. When called, NCIPC supports the 
states and local health authorities by conducting Drug Overdose 
Response Investigations (DORI), which entails a rapid and flexible 
epidemiological response. Urgent requests such as DORIs depend on the 
time and resources available, number of persons involved, and other 
circumstances unique to the urgent conditions at hand and usually 
involve the development of procedures, specific data collection 
instruments, and the collection of critical data.
    This request is for a new generic approval to conduct information 
collections during DORIs. A three-year clearance is requested to 
ensure: (1) Rapid deployment data collection tools and (2) timely 
information collection of vital information. Of particular interest is 
response to increasing trends in, or changing characteristics of, 
overdose from prescription drugs (with a special interest in opioid 
analgesics such as oxycodone or methadone; benzodiazepines such as 
alprazolam) and/or illicit drugs (e.g., heroin).
    Specifically, this request covers investigative collections with 
the

[[Page 47641]]

following aims: (1) To understand sudden increases in drug use and 
misuse associated with fatal and nonfatal overdoses; (2) to understand 
the drivers and risk factors associated with those trends; and (3) to 
identify the groups most affected. This will allow CDC to effectively 
advise states on recommended actions to control local epidemics. Thus, 
the ultimate goals of these collections are to minimize adverse health 
consequences, provide epidemiological data collection support to the 
states and, based on the findings from the investigation, appropriately 
assist with implementation of prevention and control measures.
    Data are collected by epidemiologists, psychologists, medical 
professionals, subject matter experts, and biostatisticians. Examples 
of data collection modes that may be employed during DORIs include: 
Archival record abstractions and reviews, face-to-face interviews, 
telephone interviews, web-based questionnaires, and self-administered 
questionnaires.
    For example, information collected through archival chart review 
from hospitals and medical examiners could include demographics, drug 
use history, reported medical and mental health conditions, place of 
overdose, place of death, drug paraphernalia on the scene, mode of 
administration, observers present, naloxone administration, hospital 
admittance, autopsy findings, toxicology results, and so forth. 
Information collected through interviews with representatives from 
agencies involved in preventing, intervening, or responding to drug 
overdose could include professional history, personal experience with 
drug overdose cases or investigations, prevention or intervention 
efforts engaged in, perceptions of characteristics of or changes in 
drug overdose cases (e.g., transition from opioids to heroin; 
increasing or decreasing rates), and so forth. Collection of 
information from nonfatal overdose victims, and friends and family of 
overdose victims could include substance use history, prescription drug 
history, number of providers and pharmacies used, pain history, co-
occurring health conditions (e.g., abnormal snoring indicative of 
respiratory depression), mental health conditions (e.g., depression, 
anxiety disorders), enrollment in drug treatment program, sources of 
drugs, route of drug administration, criminal history, and so forth. 
Finally, collection of spatial information could be obtained through 
city, county, and state government agencies to determine structural and 
environmental factors associated with location of overdose deaths.
    Respondent type will also vary by investigation, but will include 
organizations typically involved in prevention, intervention, and 
response to drug overdose (e.g., public health, law enforcement 
authorities, health systems, and community organizations. Respondents 
also may include victims of non-fatal drug overdoses, as well as family 
and friends of victims.
    During a DORI, data are collected once, with the rare need for 
follow-up. There are no costs to respondents other than their time.

                                                            Estimated Annualized Burden Hours
--------------------------------------------------------------------------------------------------------------------------------------------------------
                                                                                                                              Average
                                                                                             Number of       Number of      burden per     Total burden
               Type of respondent                               Form name                   respondents    responses per   response (in        hours
                                                                                                            respondent        hours)
--------------------------------------------------------------------------------------------------------------------------------------------------------
Drug Overdose Response Investigation             Drug Overdose Response Investigation              2,700               1              .5           1,350
 Participants.                                    Data Collection Instruments.
                                                                                         ---------------------------------------------------------------
    Total......................................  .......................................  ..............  ..............  ..............           1,350
--------------------------------------------------------------------------------------------------------------------------------------------------------


Leroy Richardson,
Chief, Information Collection Review Office, Office of Scientific 
Integrity, Office of the Associate Director for Science, Office of the 
Director, Centers for Disease Control and Prevention.
[FR Doc. 2014-19245 Filed 8-13-14; 8:45 am]
BILLING CODE 4163-18-P